Piramal Pharma Limited
NSE: PPLPHARMA.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter Daniel DeYoung
- Employees
- 6,719
- Headquarters
- Mumbai, India
- IPO year
- 2022
- Market cap
- ₹238.3B
- Website
- https://www.piramal.com/businesses/piramal-pharma
Loading PPLPHARMA…
Loading profile data…Frequently asked questions about PPLPHARMA
What does Piramal Pharma Limited (PPLPHARMA.NS) do?
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
Where does PPLPHARMA.NS trade?
Piramal Pharma Limited (PPLPHARMA.NS) trades on the National Stock Exchange of India.
What sector is PPLPHARMA.NS in?
Piramal Pharma Limited (PPLPHARMA.NS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Piramal Pharma Limited?
Peter Daniel DeYoung is the chief executive officer of Piramal Pharma Limited (PPLPHARMA.NS).
Where is Piramal Pharma Limited headquartered?
Piramal Pharma Limited is headquartered in India.
Does PPLPHARMA.NS pay a dividend?
Yes — Piramal Pharma Limited (PPLPHARMA.NS) paid a trailing twelve-month dividend of INR 0.14 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did PPLPHARMA.NS go public?
Piramal Pharma Limited (PPLPHARMA.NS) completed its initial public offering in 2022.